Mid-Year Report

WYETH for WYETH

Firm
Client
Income
—
Expenses
$1,820,000

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Pharmaceutical drug importation S. Con Res 21 FY 2008 Senate Budget Resolution

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA); Justice, Dept of (DOJ); Natl Security Council (NSC); SENATE; Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of

Bills named: S.Con.Res. 21 (110th)

Trade (domestic/foreign) TRD

Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Natl Security Council (NSC); Health & Human Services, Dept of (HHS); SENATE; Justice, Dept of (DOJ); Office of the Vice President of the United States; White House Office; Treasury, Dept of; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Puerto Rico Tax Incentives; Taxation of International Operations of U.S. corporations generally R&D Tax Credit; Taxation of Deferred Compensation Plans; Homeland Investment legislation

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Office of the Vice President of the United States; White House Office; Natl Security Council (NSC); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Justice, Dept of (DOJ); Treasury, Dept of; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement H.R. 1908 Patent Reform Act of 2007 S. 1145 Patent Reform Act of 2007

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Food & Drug Administration (FDA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); White House Office; Treasury, Dept of; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; SENATE; Office of the Vice President of the United States; Executive Office of the President (EOP)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Health Issues HCR

Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Medicare reimbursement for certain drugs Importation Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies Drug Compounding Alzheimer's care H.R. 2900 Food and Drug Administration Act of 2007 S.1695 Biologics Price Compeition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 Labor/HHS Appropriations Act of 2008 S. 1276 Methamphetamine Production Prevention Act of 2007 S.1082 FDA Revitalization Act of 2007 H.R. 1812 Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on Biologics Drug Importation and Counterfeiting Prescription Drug User Fees Drug Safety/Clinical Trials Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; SENATE; White House Office; Treasury, Dept of; Justice, Dept of (DOJ); Food & Drug Administration (FDA); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); State, Dept of (DOS); U.S. Trade Representative (USTR)

Bills named: H.R. 1812 (110th), S. 1276 (110th), H.R. 2900 (110th), H.R. 3043 (110th), S. 1695 (110th), S. 1082 (110th)

Consumer Issues/Safety/Products CSP

S. 1276 Methamphetamine Production Prevention Act of 2007 H.R. 970 DXM Distribution Act S.1378 DXM Distribution Act FDA reform proposals; Pseudoephedrine;

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of the Vice President of the United States; Executive Office of the President (EOP); Natl Security Council (NSC); SENATE

Bills named: S. 1378 (110th), S. 1276 (110th), H.R. 970 (110th)

Medicare/Medicaid MMM

Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 Medicare Prescription Drug Prie Negoation Act Prescription drug user fees; Methamphetamines Vaccines

LobbyistCovered position, as disclosed
LEO C JARDOT VICE PRESIDENT, GOVERNMENT RELATIONS
BRONWEN KAYE SENIOR DIRECTOR, GOVERNMENT RELATIONS
JULIE RABINOWITZ SENIOR DIRECTOR & COUNSEL, GVT RELATIONS
ANGELA WALKER RIEMER SENIOR DIRECTOR, GOVERNMENT RELATIONS

Contacted: Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Natl Security Council (NSC); Food & Drug Administration (FDA); Treasury, Dept of; State, Dept of (DOS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office; U.S. Trade Representative (USTR); Office of the Vice President of the United States

Bills named: H.R. 4 (110th), S. 1932 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.